Skip to main content

S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer

Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma

A Randomized, Double-Blind Phase II Study of Adjuvant Pembrolizumab Versus Placebo in Head and Neck Cancers at High Risk for Recurrence- the PATHWay Study

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Randomized, Double-Blind Phase II Study of Adjuvant Pembrolizumab Versus Placebo in Head and Neck Cancers at High Risk for Recurrence- the PATHWay Study

Testing Olaparib Either Alone or in Combination With Atezolizumab in BRCA Mutant Non-HER2-positive Breast Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Testing Olaparib Either Alone or in Combination With Atezolizumab in BRCA Mutant Non-HER2-positive Breast Cancer

Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS

Understanding the Pathophysiology of Migraine Pain

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Understanding the Pathophysiology of Migraine Pain

Effect of Randomization to Neuromuscular Blockade on Physical Functional Impairment and Recovery in ARDS

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Effect of Randomization to Neuromuscular Blockade on Physical Functional Impairment and Recovery in ARDS

Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States

Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial

Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 231
  • Page 232
  • Page 233
  • Page 234
  • Page 235
  • Page 236
  • Page 237
  • Page 238
  • Page 239
  • …
  • Next page Next
  • Last page Last
Subscribe to